• Home
  • R&D




  • Théa Open Innovation by Laboratoires Théa S.A.S

    Ophthalmic programs (OLX301A · OLX301D) License and Collaboration Agreement

  • Hansoh Pharmaceuticals Group Co, Ltd

    Cardiovascular/metabolic programs (GalNAc-asiRNA) License and Collaboration Agreement

  • University of Virginia School of Medicine

    GA and Wet AMD program (OLX301A) Research Collaboration

  • AM Chemicals

    GalNAc platform technology introduced

  • Charles River Laboratories

    GA & Wet AMD program (OLX301A) Toxicology Studies

  • ASTAR – IMCB(Singapore)

    A*STAR(Singapore)-KHIDI(Korea) Joint Grant Call
    Idiopathic pulmonary fibrosis program (OLX201A)

  • Korea Institute of Toxicology, Department of Inhalation Research

    Idiopathic pulmonary fibrosis program (OLX201A) Development Collaboration